Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on March 30, 2007
Chest, doi:10.1378/chest.06-2756
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
chest.06-2756v1
131/6/1718    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elizur, A.
Right arrow Articles by Cannon, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elizur, A.
Right arrow Articles by Cannon, C. L.

Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Lung Infections in Patients with Cystic Fibrosis

Arnon Elizur, MD1; Rachel C. Orscheln, MD1; Thomas W. Ferkol, MD1; Jeffrey J. Atkinson, MD2; W. Michael Dunne, Jr, PhD3; Richard S. Buller, PhD1; Jon R. Armstrong4; Elaine R. Mardis, PhD4; Gregory A. Storch, MD1,2 and Carolyn L. Cannon, MD, PhD1

1Departments of Pediatrics, Medicine 2Pathology and Immunology 3and the Genome Sequencing Center 4Washington University School of Medicine, St. Louis, MO 63110, U.S.A

Elizur_A{at}kids.wustl.edu

Abstract

Background: Panton-Valentine Leukocidin-expressing, methicillin-resistant Staphylococcus aureus (PVL+ MRSA) is an emerging pathogen world-wide causing fatal necrotizing pneumonias in otherwise healthy individuals, but has not been described in CF patients. Following two cases of patients with CF admitted with lung abscesses in association with PVL+ MRSA, we examined the incidence and the clinical characteristics of MRSA acquisition in our CF patient population.

Methods: Newly acquired MRSA isolates from patients with CF followed at St. Louis Children's Hospital were analyzed for the presence of PVL coding region, clindamycin susceptibility, staphylococcal cassette chromosome (SCC) mec type, and multi-locus sequence type. Medical records and pulmonary function studies at the time of MRSA isolation were reviewed.

Results: MRSA isolates from 40 CF patients were available for analysis. Six children (15%) were infected with PVL+ MRSA. All PVL+ organisms were clindamycin susceptible. Patients who acquired a PVL+ organism were more likely to have a focal pulmonary infiltrate on chest radiograph including cavitary lung lesions in two patients (p = 0.04), a markedly greater decline in FEV1 at the time of MRSA detection (p = 0.01), and a significantly higher WBC (p = 0.04) and absolute neutrophil count (p = 0.04). These patients were more likely to be admitted for intravenous antibiotic therapy for respiratory illnesses (p < 0.01).

Conclusions: We describe the emergence of PVL+ MRSA in our CF population in association with development of invasive lung infections including lung abscesses. Early identification and treatment of CF patients with newly acquired PVL+ MRSA may be crucial.

Key Words: Cystic fibrosis • Lung abscess • Staphylococcus




This article has been cited by other articles:


Home page
ChestHome page
D. Glikman, J. D. Siegel, M. Z. David, N. M. Okoro, S. Boyle-Vavra, M. L. Dowell, and R. S. Daum
Complex Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolates From Children With Cystic Fibrosis in the Era of Epidemic Community-Associated Methicillin-Resistant S aureus
Chest, June 1, 2008; 133(6): 1381 - 1387.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American College of Chest Physicians.